Low Evidence
Research Overview
IGF-1 LR3 Research for Muscle Growth
An evidence-based overview of research examining IGF-1 LR3 in the context of muscle growth. This page synthesizes findings from peer-reviewed literature.
Research Summary
IGF-1 LR3's extended half-life and reduced IGFBP binding make it a potent activator of the PI3K/Akt/mTOR pathway for muscle protein synthesis. Animal studies show clear hypertrophic effects. Human data is limited to extrapolation from native IGF-1 studies.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Muscle Growth
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. IGF-1 LR3 has not received regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.